BreadcrumbHome / Investors / Events and Presentations / Event Details Event Details Jump Links - All Pages OverviewPress ReleasesEvents and PresentationsSEC FilingsCorporate GovernanceStock Information Ocular Therapeutix™ Announces Topline Results of Phase 3 Clinical Trial of DEXTENZA® for the Treatment of Ocular Itching Associated with Allergic Conjunctivitis April 28, 2020 at 8:30 AM EDT Click Here for Webcast Additional Resources Investor FAQsInformation Request
Ocular Therapeutix™ Announces Topline Results of Phase 3 Clinical Trial of DEXTENZA® for the Treatment of Ocular Itching Associated with Allergic Conjunctivitis April 28, 2020 at 8:30 AM EDT Click Here for Webcast